Items Tagged ‘#Biomanufacturing’
December 19, 2022
Aspiring to deliver new cures for complex conditions
Mayo Clinic is building toward a future when biologics can cure cancer, kidney disease and diabetes. Mayo marks 2022 as a year of significant strides in accelerating science to make and deliver regenerative biotherapeutics. The goal is to offer new options, based on rigorous research in cell and gene therapies, for disorders with few available […]
Tags: #biologics, #Biomanufacturing, #cell therapy, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Biotherapeutics, CAR-T cell therapy
September 27, 2022
Julie Allickson, Ph.D. on Mayo Clinic Q&A Podcast
Through research, clinical trials and biomanufacturing, Mayo Clinic’s Center for Regenerative Biotherapeutics is working to develop new types of medicines derived from the human body to treat chronic and age-related diseases. Biologics are therapies that come from human sources — cells, blood, enzymes, tissues, genes or genetically engineered cells — for use in medicines. Biomanufacturing is focused on […]
Tags: #3D printing, #Biomanufacturing, #Cancer, #cell therapy, #Dr. Julie Allickson, #gene therapy, #Mayo Clinic Center for Regenerative Biotherapeutics
August 30, 2022
A new name for Center for Regenerative Medicine
Mayo Clinic’s Center for Regenerative Medicine has been renamed the Center for Regenerative Biotherapeutics. The name change reflects Mayo’s new strategic focus: manufacturing next-generation biotherapeutics for patients. The new name emphasizes how regenerative medicine at Mayo Clinic has evolved to advance groundbreaking discoveries toward curative products — biotherapeutics — for patients. The Center for Regenerative […]
Tags: #Biomanufacturing, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine
November 11, 2021
Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021 recap
“The future of regenerative medicine is bright,” declared Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, as she delivered the opening keynote address of the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021. Dr. Allickson is the Otto Bremer Trust Director, Biomanufacturing and Product […]
Tags: #Biomanufacturing, #Dr. Julie Allickson, #Dr. Peter Marks, #Dr. Richard Gray, #Dr. Richard Hayden, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
November 4, 2021
Mayo Clinic poised to biomanufacture a new era of biotherapeutics
ROCHESTER, Minn. — Mayo Clinic has launched a new biomanufacturing strategy that seeks to develop next-generation biotherapeutics that go beyond standard pharmaceuticals and deliver new cures for rare and complex conditions. The opportunities and challenges in this emerging field will be showcased at the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021, which will […]
Tags: #Biomanufacturing, #biotherapeutics, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
October 14, 2021
Overcoming regulatory challenges to licensing new biotherapeutics
Mayo Clinic’s Symposium on Regenerative Medicine and Surgery will explore the challenges and opportunities of bringing next-generation biotherapeutics to patients. Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, will deliver a keynote presentation addressing regulatory hurdles standing between the billions of dollars invested in regenerative […]
Tags: #Biomanufacturing, #Dr. Atta Behfar, #Dr. Julie Allickson, #Dr. Peter Marks, #Dr. Richard Hayden, #Dr. Todd Rasmussen, #Dr. William Faubion, #FDA, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
September 16, 2021
A robotic GPS for targeting, delivering regenerative biotherapies
A remote-controlled bronchoscope that acts like a GPS system hunts down hard to find lung masses and accurately biopsies them, according to a Mayo Clinic collaborative study. This multisite research, which is published in Annals of Thoracic Surgery, lays the foundation for precisely finding early stage cancer and targeting it with regenerative biotherapeutics needed to […]
Tags: #Biomanufacturing, #biotherapeutics, #bronchoscope, #Dr. Janani Reisenauer, #lung cancer, #Mayo Clinic Center for Regenerative Medicine, Dr. Julie Allickson
August 19, 2021
A new understanding of the inner workings of CAR-T cell therapy
Mayo Clinic researchers have biomanufactured chimeric antigen receptor-T cell therapy (CAR-T cell therapy) in a new way to track the cells’ cancer fighting journey and predict toxic side effects. This Mayo Clinic breakthrough, published in Cancer Immunology Research, also could unravel the mystery of how to unleash CAR-T cell therapy to destroy solid tumors. “This […]
Tags: #Biomanufacturing, #CAR-T cell therapy, #Dr. Saad Kenderian, #Mayo Clinic Center for Regenerative Medicine, #regenerative iimmunotherapies
June 4, 2021
New director named for Center for Regenerative Medicine
Julie Allickson, Ph.D., has been named the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine and the Otto Bremer Trust Director, Biomanufacturing and Product Development, Center for Regenerative Medicine. Dr. Allickson joins Mayo Clinic from Wake Forest Institute for Regenerative Medicine at Wake Forest School of Medicine, where she […]
Tags: #Biomanufacturing, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine
February 1, 2021
Advancing cell-based regenerative therapy for heart failure
February is American Heart Month, a time to highlight innovative research that seeks to advance cellular therapy as a new option for restoring heart health. One of the latest discoveries in the Center for Regenerative Medicine and Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program established a way to engineer stem cells that activate regenerative […]
Tags: #Atta Behfar, #Biomanufacturing, #Cardiac regeneration, #cardiopoietic cells, #Mark Li, #Mayo Clinic Alix School of Medicine, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Graduate School of Biomedical Sciences